These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3356110)

  • 1. Caffeine clearance and biotransformation in patients with chronic liver disease.
    Scott NR; Stambuk D; Chakraborty J; Marks V; Morgan MY
    Clin Sci (Lond); 1988 Apr; 74(4):377-84. PubMed ID: 3356110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease.
    Scott NR; Stambuk D; Chakraborty J; Marks V; Morgan MY
    Br J Clin Pharmacol; 1989 Feb; 27(2):205-13. PubMed ID: 2713214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine metabolism in patients with chronic liver disease.
    Rodopoulos N; Wisén O; Norman A
    Scand J Clin Lab Invest; 1995 May; 55(3):229-42. PubMed ID: 7638557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary metabolites of caffeine in pregnant women.
    Scott NR; Chakraborty J; Marks V
    Br J Clin Pharmacol; 1986 Oct; 22(4):475-8. PubMed ID: 3768258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of liver disease on urine caffeine metabolite ratios.
    Denaro CP; Wilson M; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 1996 Jun; 59(6):624-35. PubMed ID: 8681487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine clearance by two point analysis: a measure of liver function in chronic liver disease.
    Wittayalertpanya S; Israsena S; Thamaree S; Tongnopnoua P; Komolmit P
    Tokai J Exp Clin Med; 1996 Dec; 21(4-6):195-201. PubMed ID: 9300980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine test assessment for measuring liver function in critically ill patients.
    Calatayud O; Rodríguez M; Sánchez-Alcaraz A; Ibáñez P
    J Clin Pharm Ther; 1995 Feb; 20(1):23-9. PubMed ID: 7775610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine elimination in cirrhotic and non-cirrhotic liver disease of different etiology.
    Joeres R; Brachtel D; Gallenkamp H; Hofstetter G; Klinker H; Zilly W; Richter E
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():56-61. PubMed ID: 7483716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine excretion of caffeine and select caffeine metabolites is common in the U.S. population and associated with caffeine intake.
    Rybak ME; Sternberg MR; Pao CI; Ahluwalia N; Pfeiffer CM
    J Nutr; 2015 Apr; 145(4):766-74. PubMed ID: 25833779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine metabolism in the newborn.
    Aldridge A; Aranda JV; Neims AH
    Clin Pharmacol Ther; 1979 Apr; 25(4):447-53. PubMed ID: 428190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine clearance test: a quantitative liver function assessment in patients with liver cirrhosis.
    Shyu JK; Wang YJ; Lee SD; Lu RH; Lo KJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 May; 57(5):329-34. PubMed ID: 8768380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeine clearance study in hepatocellular carcinoma.
    Tangkijvanich P; Wittayalertpanya S; Kusonsolboon T; Thong-Ngam D; Mahachai V
    J Med Assoc Thai; 1999 Mar; 82(3):297-303. PubMed ID: 10410486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple useful method for the determination of hepatic function in patients with liver cirrhosis using caffeine and its three major dimethylmetabolites.
    Tanaka E; Ishikawa A; Yamamoto Y; Osada A; Tsuji K; Fukao K; Misawa S; Iwasaki Y
    Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):336-41. PubMed ID: 1428297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of smoking on caffeine elimination by the liver in patients with chronic liver diseases].
    Hartleb M; Nowak A; Becker A; Mańczyk I
    Pol Arch Med Wewn; 1990 Dec; 84(6):351-6. PubMed ID: 2092323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum metabolite/caffeine ratios as a test for liver function.
    Jodynis-Liebert J; Flieger J; Matuszewska A; Juszczyk J
    J Clin Pharmacol; 2004 Apr; 44(4):338-47. PubMed ID: 15051740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separation, pre-concentration, and HPLC analysis of methylxanthines in urine samples.
    Zydroń M; Baranowski J; Baranowska I
    J Sep Sci; 2004 Oct; 27(14):1166-72. PubMed ID: 15537072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine clearance by enzyme multiplied immunoassay technique: a simple, inexpensive, and useful indicator of liver function.
    McDonagh JE; Nathan VV; Bonavia IC; Moyle GR; Tanner AR
    Gut; 1991 Jun; 32(6):681-4. PubMed ID: 2060878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of total overnight salivary caffeine assessment (TOSCA) for liver function evaluation in compensated cirrhotic patients.
    Tarantino G; Conca P; Capone D; Gentile A; Polichetti G; Basile V
    Eur J Clin Pharmacol; 2006 Aug; 62(8):605-12. PubMed ID: 16841221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of theophylline metabolites in healthy adults.
    Rodopoulos N; Norman A
    Scand J Clin Lab Invest; 1997 May; 57(3):233-40. PubMed ID: 9238759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Resorption and biotransformation of model substances in primary idiopathic hemochromatosis (siderophilia)].
    Hoffmann A; Müller A; Reinhardt M; Truckenbrodt J; Jorke D
    Gastroenterol J; 1989; 49(3):113-7. PubMed ID: 2629779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.